Funding
BLOOD, HEART, LUNG
Open access funding provided by University of the Witwatersrand. SBG is funded by the Carnegie Corporation of New York (Grant No. G-19-57145), The Swedish International Development Cooperation Agency (Grant No. 54100113), Uppsala Monitoring Centre and the DELTAS Africa Initiative (Grant No. 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the Fellow. WDFV and STL-E are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (Award Number UG3HL156388). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.